ROIVANT SCIENCES LTD. Number of Reportable Segments
ROIVANT SCIENCES LTD. (ROIV) reported Number of Reportable Segments of 1 segment for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Segment Reporting
us-gaap:NumberOfReportableSegments · last filed 2026-08-06
- ROIVANT SCIENCES LTD. number of reportable segments for the quarter ending 2025-06-30 was 1.00 Segment, a 0.00% change year-over-year.
- ROIVANT SCIENCES LTD. number of reportable segments for the quarter ending 2024-06-30 was 1.00 Segment, a 0.00% change year-over-year.
- ROIVANT SCIENCES LTD. number of reportable segments for the quarter ending 2023-06-30 was 1.00 Segment.
- ROIVANT SCIENCES LTD. number of reportable segments for fiscal 2025 was 1.00 Segment, a 0.00% change from fiscal 2024.
- ROIVANT SCIENCES LTD. number of reportable segments for fiscal 2024 was 1.00 Segment, a 0.00% change from fiscal 2023.
- ROIVANT SCIENCES LTD. number of reportable segments for fiscal 2023 was 1.00 Segment.
Segment
| Period end | Number of Reportable Segments 3 month | Number of Reportable Segments 6 month | Number of Reportable Segments 9 month | Number of Reportable Segments 12 month |
|---|---|---|---|---|
| 2025-06-30 | 1.00 Segment 10-Q · filed 2025-08-11 | |||
| 2025-03-31 | 1.00 Segment 10-K · filed 2025-05-29 | |||
| 2024-12-31 | 1.00 Segment 10-Q · filed 2025-02-10 | |||
| 2024-09-30 | 1.00 Segment 10-Q · filed 2024-11-12 | |||
| 2024-06-30 | 1.00 Segment 10-Q · filed 2024-08-09 | |||
| 2024-03-31 | 1.00 Segment 10-K · filed 2024-05-30 | |||
| 2023-12-31 | 1.00 Segment 10-Q · filed 2024-02-13 | |||
| 2023-09-30 | 1.00 Segment 10-Q · filed 2023-11-13 | |||
| 2023-06-30 | 1.00 Segment 10-Q · filed 2023-08-14 | |||
| 2023-03-31 | 1.00 Segment 10-K · filed 2023-06-28 | |||
| 2022-12-31 | 1.00 Segment 10-Q · filed 2023-02-13 | |||
| 2022-09-30 | 1.00 Segment 10-Q · filed 2022-11-14 |
segment
| Period end | Number of Reportable Segments 3 month | Number of Reportable Segments 6 month | Number of Reportable Segments 9 month | Number of Reportable Segments 12 month |
|---|---|---|---|---|
| 2026-06-30 | 1.00 segment 10-Q · filed 2026-08-06 | |||
| 2026-03-31 | 1.00 segment 10-K · filed 2026-05-20 | |||
| 2025-12-31 | 1.00 segment 10-Q · filed 2026-02-06 | |||
| 2025-09-30 | 1.00 segment 10-Q · filed 2025-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |